Fidec Corporation
11 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants (NCT07010822) | Fidec Corporation | 2025-12-08 |
| A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2 (NCT05677256) | Fidec Corporation | 2023-11-09 |
| Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants (NCT05033561) | Fidec Corporation | 2021-12-16 |
| Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine (NCT05166031) | Fidec Corporation | 2020-12-01 |
| A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine (NCT03554798) | Fidec Corporation | 2018-12-04 |
| A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV (NCT03239496) | Fidec Corporation | 2017-10-23 |
Track Fidec Corporation automatically
Every clearance here is in the API, with alerts when new ones post.